M. Zatelli

Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation?

C. Pilon, E. D. degli Uberti, F. Fallo, 2008, Clinical endocrinology.

SPECT- and PET-Based Patient-Tailored Treatment in Neuroendocrine Tumors: A Comprehensive Multidisciplinary Team Approach

Patrick M Colletti, Egesta Lopci, Ken Herrmann, 2015, Clinical nuclear medicine.

Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.

J. Taylor, M. Culler, D. Piccin, 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.

J. Taylor, M. Culler, F. Tagliati, 2001, The Journal of clinical endocrinology and metabolism.